Published: May 07, 2021
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health-
SALT LAKE CITY (BUSINESS WIRE) Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are
Robert S. Langer, an Institute Professor at MIT and the most cited engineer in history and 4th most cited individual in any field who has authored more than 1,500 scientific papers. He is also a co-founder and board member of Moderna.
May 07, 2021
The implementation of a smartphone-based application to aid with communication about STEMI patients coming in from the field has enabled one large health system to drop its EMS-to-balloon time by 10 minutes, according to a new study.
“With this device you can send text, pictures, video, vitals, and it not only goes to the ED but a whole system,” senior researcher Amir Lofti, MD (Baystate Medical Center, Springfield, MA), told TCTMD. “All that information is communicated to a group of people that is preselected and therefore everybody is on the same page. Everybody knows there s a patient coming, you have real-time GPS location so they know exactly how far the patient is out, they know when the patient arrives from the rig, and we know their clinical status or if their clinical status changes. So we re all prepared for them in the ED and then the cath lab.”
May 07, 2021
Patients with cardiovascular disease who are under added strain due to sociodemographic factors, such as financial instability and food insecurity, are less likely to take steps to protect themselves from COVID-19 and less able to avoid situations, like crowded work or living spaces, that carry the risk of exposure to SARS-CoV-2.
The results, from a survey of US adults during the pandemic’s first wave, are set to be presented at the virtual American College of Cardiology (ACC) 2021 Scientific Session later this month and are now published in
Circulation: Cardiovascular Quality and Outcomes.
More of TCTMD s coverage on our COVID-19 hub.
Sleep duration linked to heart disease risk
Both too little
Credit: Malte Mueller/Getty Images
It’s well established that sleep is vital to health and wellbeing, and that sleep deprivation has a host of adverse outcomes. What’s perhaps less well known is that excess sleep – commonly defined as more than 8–9 hours per night – can be too much of a good thing.
Both ends of the spectrum have been linked with metabolic, hormonal and immune changes, premature mortality, diabetes, obesity, hypertension and heart disease risk.
A large population study in the US adds new evidence to the mix, suggesting that 6–7 hours of sleep each night could be optimum for heart health.